Pneumologia

Atualização clínica da COVID-19 para o médico emergencista: parada cardíaca dentro e fora do ambiente hospitalar.

18 Mai, 2022 | 17:01h

Clinical update on COVID-19 for the emergency clinician: Cardiac arrest in the out-of-hospital and in-hospital settings – The American Journal of Emergency Medicine

Conteúdos relacionados:

Clinical update on COVID-19 for the emergency and critical care clinician: Medical management – American Journal of Emergency Medicine

Clinical update on COVID-19 for the emergency clinician: Presentation and evaluation – The American Journal of Emergency Medicine

---

Estudo RECOVERY | Por questões de segurança, o recrutamento de pacientes com Covid-19 apresentando hipóxia sem oxigênio ou recebendo oxigênio simples para doses mais altas de corticosteroides foi encerrado.

18 Mai, 2022 | 17:00h

Recruitment to higher dose corticosteroids closed for patients with hypoxia on no oxygen or receiving simple oxygen – University of Oxford

---

Estudo de coorte | Trombose venosa ou arterial e mortes em casos de COVID-19.

18 Mai, 2022 | 16:58h

Venous or arterial thrombosis and deaths among COVID-19 cases: a European network cohort study – The Lancet Infectious Diseases

Comentário convidado: Risk of arterial and venous thromboses after COVID-19 – The Lancet Infectious Diseases

Comunicado de imprensa: COVID-19’s high blood clot risk – University of Oxford

 

Comentário no Twitter

Clots with Covid: Multi-national report of over 900,000 people indicates propensity of risk for arterial and venous thrombi is in men, with increasing age, and association with fatalities (4-fold in non-hospitalized) https://t.co/muGnDld4Um pic.twitter.com/6bLiHPLInm

— Eric Topol (@EricTopol) May 13, 2022

Sob licença de Creative Commons Attribution (CC BY 4.0)

---

Estudo de coorte | Risco de morte e reinternação não planejada após alta hospitalar de internação por COVID-19.

18 Mai, 2022 | 16:56h

The risk of death or unplanned readmission after discharge from a COVID-19 hospitalization in Alberta and Ontario – Canadian Medical Association Journal

Comentário: Study: Readmission rate for COVID-19 is 11% – CIDRAP

---

Estudo randomizado | Cigarros eletrônicos vs. adesivos de nicotina para cessação do tabagismo na gestação.

18 Mai, 2022 | 16:54h

Electronic cigarettes versus nicotine patches for smoking cessation in pregnancy: a randomized controlled trial – Nature Medicine

Comunicado de imprensa: E-cigarettes may be more effective than nicotine patches in helping pregnant women who smoke quit, and are just as safe – Queen Mary, University of London

Comentário: E-cigarettes ‘as safe as nicotine patches’ for pregnant smokers trying to quit – The Guardian

 

Comentário no Twitter (fio – clique para saber mais)

New paper in @NatureMedicine.
Results from a @NIHRresearch funded multi-centre UK trial of #ecigarettes for smoking cessation in pregnancy 🤰
Found that ECs for smoking cessation in pregnancy may be more effective than NRT.
Led by colleagues @QMUL 1/8. https://t.co/OUZxfZB4Cc

— Linda Bauld (@LindaBauld) May 16, 2022

 

---

Estudo de coorte | Sustentabilidade de uma intervenção de apoio a decisão clínica voltada para estimular o cuidado ambulatorial de pacientes selecionados com embolia pulmonar aguda.

18 Mai, 2022 | 16:45h

Sustainability of a Clinical Decision Support Intervention for Outpatient Care for Emergency Department Patients With Acute Pulmonary Embolism – JAMA Network Open

Conteúdo relacionado: Outpatient versus inpatient treatment for acute pulmonary embolism – Cochrane Library

 

Comentário no Twitter

This multicenter cohort study of ED patients with acute pulmonary embolism found the initial increase in outpatient management from a physician champion-led, EHR-embedded clinical decision support intervention was sustained 4 years later. https://t.co/UPf8pAOTry

— JAMA Network Open (@JAMANetworkOpen) May 16, 2022

 

---

M-A | Prevalência e valor prognóstico da sarcopenia preexistente em pacientes sob ventilação mecânica.

18 Mai, 2022 | 16:25h

Prevalence and prognostic value of preexisting sarcopenia in patients with mechanical ventilation: a systematic review and meta-analysis – Critical Care

---

Estudo randomizado | Efeito da posição prona na entubação endotraqueal de pacientes com COVID-19 e insuficiência respiratória aguda.

17 Mai, 2022 | 12:13h

Effect of Awake Prone Positioning on Endotracheal Intubation in Patients With COVID-19 and Acute Respiratory Failure: A Randomized Clinical Trial – JAMA

Conteúdos relacionados:

Assessment of Awake Prone Positioning in Hospitalized Adults With COVID-19: A Nonrandomized Controlled Trial – JAMA Internal Medicine

Awake prone positioning for non-intubated patients with COVID-19-related acute hypoxaemic respiratory failure: a systematic review and meta-analysis – The Lancet Respiratory Medicine

Prone positioning of patients with moderate hypoxaemia due to covid-19: multicentre pragmatic randomised trial (COVID-PRONE) – The BMJ

RCT: Prone positioning of patients with moderate hypoxia due to COVID-19 – medRxiv

Awake prone positioning for COVID-19 acute hypoxaemic respiratory failure: a randomised, controlled, multinational, open-label meta-trial – The Lancet Respiratory Medicine

Awake prone positioning in patients with hypoxemic respiratory failure due to COVID-19: the PROFLO multicenter randomized clinical trial – Critical Care

Prone Positioning of Nonintubated Patients With Coronavirus Disease 2019—A Systematic Review and Meta-Analysis – Critical Care Medicine

 

Comentário no Twitter

In this trial, in patients with acute hypoxemic respiratory failure from #COVID19, prone positioning, compared with usual care without prone positioning, did not significantly reduce endotracheal intubation at 30 days. https://t.co/1RyYRtcrYj

— JAMA (@JAMA_current) May 15, 2022

 

---

Estudo randomizado | Inalador de resgate com dose fixa combinada de albuterol-budesonida para asma.

17 Mai, 2022 | 12:10h

Albuterol–Budesonide Fixed-Dose Combination Rescue Inhaler for Asthma – New England Journal of Medicine (link para o resumo – $ para o texto completo)

 

Comentário no Twitter

The risk of severe asthma exacerbation was significantly lower with as-needed use of a fixed-dose combination of 180 μg of albuterol and 160 μg of budesonide than with albuterol alone. #ATS2022 https://t.co/MRGaUaGVwj pic.twitter.com/6BZX9Q6WxX

— NEJM (@NEJM) May 15, 2022

 

---

Estudo de um inibidor de fosfodiesterase 4B na fibrose pulmonar idiopática.

17 Mai, 2022 | 12:09h

Trial of a Preferential Phosphodiesterase 4B Inhibitor for Idiopathic Pulmonary Fibrosis – New England Journal of Medicine (link para o resumo – $ para o texto completo)

 

Comentário no Twitter

https://twitter.com/NEJM/status/1525878684380430343

 

---